Cos. Spar Over PTO Re-Exam Of Stem Cell Patents
Palo Alto, Calif.-based StemCells said Tuesday that the patents had been upheld in re-examination with minor amendments. But a Neuralstem executive said its opponent had “completely mischaracterized” the changes and called them numerous and substantial.
The PTO has published notices of intent...
To view the full article, register now.